Gettler Samuel, Rothe Marti, Grin Caron, Grant-Kels Jane
Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Am J Clin Dermatol. 2003;4(9):597-608. doi: 10.2165/00128071-200304090-00002.
The optimal treatment of pyoderma gangrenosum includes a combination of local wound care and systemic medications. Oral and pulse intravenous corticosteroids have traditionally been the most commonly recommended first-line systemic therapies. Cyclosporine, with or without corticosteroids, has more recently emerged as a first-line systemic treatment. A multitude of immunosuppressive and immune-modulating medications, as well as antimicrobial agents with anti-inflammatory properties have also been widely prescribed. Often, it is difficult to achieve control of aggressive cases of pyoderma gangrenosum, necessitating administration of a combination of systemic therapies. Furthermore, patients recalcitrant to one or many medications are frequently reported. Concomitant disease, intolerance to a class of medications, and the patient's response to prior therapies can help guide a practitioner in choosing the optimal treatment of pyoderma gangrenosum.
坏疽性脓皮病的最佳治疗方法包括局部伤口护理和全身用药相结合。口服和静脉冲击使用皮质类固醇传统上一直是最常推荐的一线全身治疗方法。环孢素,无论是否联合皮质类固醇,最近已成为一线全身治疗药物。多种免疫抑制和免疫调节药物以及具有抗炎特性的抗菌药物也被广泛应用。通常,控制坏疽性脓皮病的侵袭性病例很困难,需要联合使用多种全身治疗方法。此外,经常有患者对一种或多种药物治疗无效的报道。合并疾病、对某类药物不耐受以及患者对先前治疗的反应有助于指导医生选择坏疽性脓皮病的最佳治疗方法。